Aptus Pharma Limited has announced that its Board of Directors will meet on March 24, 2026, to consider increasing authorized share capital and recommending bonus equity shares. The trading window will remain closed from March 18 to March 26, 2026, in line with SEBI regulations.
Aptus Pharma Limited has formally notified the Bombay Stock Exchange of its upcoming board meeting. The agenda includes key corporate actions that could significantly impact shareholder value and market sentiment.
Board Meeting Agenda
The meeting will be held at Rajkot, Gujarat, where directors will deliberate on two major proposals: an increase in authorized share capital and the consideration of issuing bonus equity shares. Both actions are subject to shareholder approval.
Regulatory Compliance
In accordance with SEBI’s Listing Obligations and Disclosure Requirements, Aptus Pharma has closed its trading window for insiders and designated persons to prevent any unfair trading advantage.
Key Highlights
-
Increase in authorized share capital under review
-
Proposal to recommend bonus equity shares
-
Board meeting scheduled for March 24, 2026
-
Trading window closed from March 18 to March 26, 2026
-
Actions subject to shareholder approval
Sources: Aptus Pharma Limited Disclosure to Stock Exchanges